Evidence map›Paper›PMID 41257783›Full record

ArticleParasites & vectors2025

A novel biomarker of human exposure to Aedes albopictus based on the Ag5-3 salivary protein from the tiger mosquito.

Maria Greta Dipaola, Eleonora Perugini, Giulia Mancini, Nicolò Gennari, Paola Serini, Giulia Bevivino, Alessio Borean, Fabrizio Lombardo, Marco Pombi, Fabrizio Montarsi and 3 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Maria Greta Dipaola *Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Eleonora Perugini *Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Giulia ManciniDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.
Nicolò GennariDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.
Paola SeriniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Giulia BevivinoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Alessio BoreanDepartment of Transfusion Medicine, San Martino Hospital, Belluno, Italy.
Fabrizio LombardoDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Marco PombiDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Fabrizio MontarsiIstituto Zooprofilattico Sperimentale Delle Venezie, Legnaro, Italy.
Paolo GabrieliDepartment of Biosciences, University of Milan, Milan, Italy.
Federico FornerisDepartment of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.
Bruno ArcàDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. bruno.arca@uniroma1.it.

Funding

EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases PE00000007 INF-ACTSapienza Università di Roma PhD program in Infectious Diseases, Microbiology and Public HealthSapienza Università di Roma RM124190FDE3A264
6 · The paper itself

Abstract

backgroundMosquito-borne arboviral diseases represent a growing threat and serious worldwide concern for public health authorities. Host immunoglobulin G (IgG) responses to mosquito salivary antigens emerged as a useful additional tool to evaluate human-vector contact, which is crucial for transmission risk assessment and planning vector control interventions. We previously reported that IgG responses to the Aedes albopictus 34k2 salivary protein (al34k2) are suitable, although with some limitations, to reveal variation of human exposure to the tiger mosquito. In this study we evaluated the Ae. albopictus Ag5-3 (alAg5-3), an Antigen 5 family member specifically and abundantly expressed in the saliva of adult females.

methodsIgG responses to recombinant alAg5-3, as well as to a combination of alAg5-3 and al34k2, were measured in a set of sera previously collected from healthy human blood donors before and after the summer season of exposure to mosquito bites. Surveys were conducted in two districts of Northeast Italy, Padua and Belluno, with different density and history of colonization by the tiger mosquito Ae. albopictus.

resultsA preliminary pilot study, performed on a small subset of individuals from Padua, indicated that alAg5-3 was more immunogenic than al34k2 and may be suitable to detect variations of exposure to Ae. albopictus. Analysis of the whole set of 523 sera showed that anti-alAg5-3 IgG levels significantly increased, in both study areas, after the summer period of high mosquito density. However, differences between the two study sites were only found when a mixture of the two antigens, alAg5-3 and al34k2, was used.

conclusionsIgG responses to alAg5-3 represent a novel appropriate marker to evaluate seasonal variation of human exposure to Ae. albopictus and, because of its higher sensitivity, it appears preferable to al34k2, especially for longitudinal studies in conditions of low-to-moderate mosquito density. However, the combination of both antigens may be a better surrogate of Ae. albopictus saliva since it allows the detection of both temporal and spatial variations of exposure to Ae. albopictus bites. The high conservation of the Ag5-3 protein among Aedes species suggests it may be exploited to also reveal exposure to Aedes aegypti and perhaps to other Aedes species.

Indexed as

AedesBiomarkersInsect ProteinsMosquito VectorsSalivary Proteins and PeptidesAdultAnimalsFemaleHumansImmunoglobulin GInsect Bites and StingsItalyMalePilot ProjectsSalivaBiomarkersImmunoglobulin GInsect ProteinsSalivary Proteins and Peptides34k2Aedes albopictusAg5-3Host exposureHuman-vector contactSalivary proteinSerological markerVector control

Identifiers

PMID41257783
PMCPMC12628915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.